LICENSE AGREEMENTLicense Agreement • August 14th, 2013 • Access Pharmaceuticals Inc • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”), is made and entered into on June 6, 2013 (the “Effective Date”) by and between (i) AMAG Pharmaceuticals, Inc., a Delaware corporation, with its principal place of business located at 100 Hayden Ave., Lexington, MA 02421 (“AMAG”) and (ii) Access Pharmaceuticals, Inc., a Delaware corporation, with its principal place of business located at 2600 Stemmons Freeway, Suite 176, Dallas TX 75207 (“Access”) (AMAG and Access are each a “Party,” and collectively the “Parties”).
